Navigation Links
YM BIOSCIENCES', EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Date:8/21/2007

MISSISSAUGA, ON, Aug. 21 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX: YMI, TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that Oncoscience AG (Wedel, Germany), its European partner for the development of the humanized EGFR-targeting monoclonal antibody, nimotuzumab, has advised that two additional late-stage trials have been cleared to commence in Europe.

- A randomized multi-centre study in which nimotuzumab and the current

standard of care (radiotherapy with concomitant and adjuvant

temozolomide) will be compared to the current standard of care in

patients with glioblastoma multiforme (GBM). This Phase III

first-line study is expected to recruit 150 patients in approximately

24 months. The primary end-point for this trial is Progression-Free

Survival with Response Rate and Symptom Control among the secondary

endpoints.

- A randomized, placebo-controlled, multi-centre Phase IIb/IIIa study

in chemotherapy-naive patients with locally advanced or metastatic

pancreatic cancer who will be treated with either gemcitabine plus

nimotuzumab or gemcitabine plus placebo. This trial is expected to

recruit 188 patients requiring approximately 24 months. The primary

end-points for this trial are Time to Tumor Progression (TTP) and

Overall Survival with Quality of Life and Response Rate among the

secondary endpoints. YM BioSciences anticipates that it will extend

the European trial in pancreatic cancer into Canada by submitting the

protocol to Canadia
'/>"/>

SOURCE YM BioSciences Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. Speaker announces business members of IT Task Force
6. Doyle announces technology tax credits for Berbee
7. Doyle announces new energy, global warming policies
8. Doyle announces $80M renewable energy strategy
9. GE announces first installation of Discovery VCT
10. UWM announces winners of RGI awards
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... September 2009 Converting the trash that fills the ... both the growing energy crisis and to tackling carbon ... published in Global Change Biology: Bioenergy , reveals ... cut global carbon emissions by 80%. Biofuels produced ...
... of Michigan physicists have created the first atomic-scale ... the goal of producing "designer dots" that can ... called artificial atoms or nanoparticles---are tiny semiconductor crystals ... light-emitting devices and other technologies. Each dot is ...
... ... ClearTrial Clinical Trial Operations (CTO) software featuring new ClearTrial TRACK provides integrated planning, ... ... (PRWEB) September 29, 2009 -- ClearTrial ( www.cleartrial.com ), the leading provider of ...
Cached Biology Technology:U-M physicists create first atomic-scale map of quantum dots 2ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development 2ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development 3ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development 4
(Date:4/16/2014)... Wash. Geologic and soil processes are to blame ... Ohio, according to a study published recently in the ... of 842 soil samples from all corners of Ohio ... the screening level of concern recommended by the U.S. ... public, say the authors, who note that regulatory levels ...
(Date:4/15/2014)... Irvine neurobiologists have found that genetically modified neural stem ... of mice with the symptoms and pathology of Alzheimer,s ... Stem Cells Research and Therapy , and the ... mouse models. , Alzheimer,s disease, one of the ... of the protein amyloid-beta in the brain in the ...
(Date:4/15/2014)... early as 2020 how high sea levels will rise ... researchers including Florida International University scientist Rene Price. , ... (NSF) Florida Coastal Everglades Long-Term Ecological Research (LTER) site, ... from coral reefs to deserts, mountains to salt marshes ... rise is one of the most certain consequences of ...
Breaking Biology News(10 mins):Significant baseline levels of arsenic found in Ohio soils are due to natural processes 2Significant baseline levels of arsenic found in Ohio soils are due to natural processes 3Significant baseline levels of arsenic found in Ohio soils are due to natural processes 4UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2Long-term predictions for Miami sea level rise could be available relatively soon 2
... Santa Barbara, CA The Bren School-based authors of a ... have observed toxicity to marine organisms resulting from exposure ... be toxic under similar conditions. Lead author and assistant ... Lenihan both Bren School professors and lead scientists at ...
... In August 2010, an entomologist at the University of California, Riverside ... never been seen in the United States until then. Nearly ... strongly suggesting that the wasp is well established in the country. ... millimeter long and arrived in North America from Europe. It ...
... 2012The time for commercial development of gene therapy has come. ... deserve access to the technology, which has demonstrated both its ... Human Gene Therapy in a provocative commentary ... and Human Gene Therapy (HGT) Methods are ...
Cached Biology News:Nano form of titanium dioxide can be toxic to marine organisms 2Wasp found in upstate New York shows up in Southern California 2Gene therapy is a 'disruptive science' ready for commercial development 2
... solution is an isotonic, balanced salt solution. It ... permits the storage of whole blood at refrigerator ... equal volume of blood is collected into a ... mixed. The solution is placed in a refrigerator ...
... Hollandes is a fixative useful for routine ... It is stable and will decalcify small ... Hollande's can be stained successfully with most ... solution stabilizes red blood cell membranes and ...
... a single-channel sample processing head, an 8-channel ... dispenser all in one compact, affordable product. ... tips, the Precision XS autoclavable and organic ... for transferring larger volumes. Intuitive Precision Power ...
... The RapidPlate 96/384 workstation offers precise 96 ... scalable format. Utilizing 100ul and 200ul disposable ... delivers excellent accuracy and precision across a ... rotary deck includes two positions that enable ...
Biology Products: